ROBO Global Healthcare Technology and Innovation ETF

HTEC

Market cap $53.5M

The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.

Healthcare technology continues to offer a powerful combination of health care investing durability and tech innovation upside. In an uncertain market, the segment can often prove a reliable source of performance for portfolios.

Healthcare has been the worst-performing sector in the S&P 500 this year. But when it comes to unlocking potential capital growth ahead, that may not be all bad news.

The future of healthcare is being forged at the intersection of biology and technology. Much like software and data analytics reshaped industries like finance and retail, a similar transformation is now creating a new landscape for investors in medicine.

On this week's episode of ETF Prime, Zeno Mercer, senior research analyst at TMX VettaFi, joins host Nate Geraci to discuss the evolution of healthcare technology.

Healthcare and technology innovation has far-reaching impacts that can truly transform and save lives. One area of ongoing focus is the growing challenge posed by heart disease.

Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.

Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?

The Health Care Select Sector SPDR ETF (XLV) was up approximately 6% year-to-date as of January 29. While it is still early days, this performance is already twice as robust as the sector ETF's performance for all of 2024.

Looking for ETFs with a strong case for upside this year? With many investors wary of concentration risk, now could be the time to diversify into other exciting areas.